Intas Pharmaceuticals Ltd.

Ahmadābād, India

Intas Pharmaceuticals Ltd.

Ahmadābād, India
SEARCH FILTERS
Time filter
Source Type

Patent
Intas Pharmaceuticals Ltd. | Date: 2017-08-02

This present invention relates to pharmaceutical compositions comprising cyclophosphamide alone and/or in combination with one or more pharmaceutical active ingredients and one or more pharmaceutically acceptable excipients wherein the cyclophosphamide has D90 particle size less than 100 microns.


Patent
Intas Pharmaceuticals Ltd | Date: 2017-02-08

The present invention relates to novel and thermostable lyophilized pharmaceutical composition of Romiplostim (Fc-peptide fusion protein) along with buffer, bulking agent, stabilizer, and surfactant at pH range of 4.0-6.0.


Patent
Intas Pharmaceuticals Ltd. | Date: 2017-02-08

Abstract The present invention relates to a liquid pharmaceutical composition comprising a conjugated erythropoietin, buffer, sugar, tonicity modifier and amino acid as an aggregation inhibitor. More preferably the present invention provides a stable pharmaceutical composition which encompasses conjugated erythropoietin comprising acetate buffer, sucrose, arginine and sodium chloride and maintained at a pH of about 4.9 to 5.3.


Patent
Intas Pharmaceuticals Ltd. | Date: 2015-02-18

A liquid pharmaceutical composition having an anti-TNF antibody, a buffer, a stabilizer, and a surfactant.


Patent
Intas Pharmaceuticals Ltd. | Date: 2015-02-27

A liquid pharmaceutical composition having a conjugated erythropoietin, buffer, sugar, tonicity modifier and amino acid as an aggregation inhibitor. The liquid pharmaceutical composition provides a stable pharmaceutical composition which encompasses conjugated erythropoietin, acetate buffer, sucrose, arginine and sodium chloride which is maintained at a pH of about 4.9 to 5.3.


Patent
Intas Pharmaceuticals Ltd. | Date: 2015-03-24

A novel and thermostable lyophilized pharmaceutical composition of Romiplostim (Fcpeptide fusion protein) along with buffer, bulking agent, stabilizer, and surfactant at pH range of 4.0-6.0.


Patent
Intas Pharmaceuticals Ltd. | Date: 2017-02-08

The present invention relates to a liquid pharmaceutical composition comprising an anti-TNF antibody, buffer, stabilizer, and surfactant.


Patent
Intas Pharmaceuticals Ltd | Date: 2014-04-28

A polynucleotide sequence and a method for Ranibizumab cloning, expression and production having better yield and biologically active protein.


Patent
INTAS PHARMACEUTICALS Ltd | Date: 2015-02-23

The present invention relates to a stable transdermal gel composition comprising Testosterone, a penetration enhancer, a gelling agent with pharmaceutically acceptable excipients. Further, the invention relates to the method of administering the said transdermal gel and its uses thereof.


Patent
INTAS PHARMACEUTICALS Ltd | Date: 2014-09-29

A pharmaceutical compositions having fixed dose combinations of capecitabine and cyclophosphamide, processes for the preparation thereof, and their use to treat cancer diseases.

Loading Intas Pharmaceuticals Ltd. collaborators
Loading Intas Pharmaceuticals Ltd. collaborators